Synergistic antifungal interaction between miconazole nitrate and chlorhexidine acetate

International Journal of Pharmaceutics

Volumn 173, Issue 1-2, 1998, Pages 3-11

  Codd, Janet E ^a   Deasy, P B ^a  

^a TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Antifungal interaction; Chlorhexidine acetate; Isobologram; Miconazole nitrate; Synergy

Indexed keywords

CHLORHEXIDINE ACETATE; CREMOPHOR; MICONAZOLE NITRATE;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DRUG POTENTIATION; LOZENGE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0032428011     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(98)00227-0     Document Type: Article

References (21)

1. Beggs, W.H., 1984. Growth phase in relation to ketoconazole and miconazole susceptibilities of Candida albicans. Antimicrob. Agents Chemother. 25, 316-318.
2. Berenbaum, M.C., 1978. A method for testing for synergy with any number of agents. J. Infect. Dis. 137, 122-130.
3. Cameron, M.L., Schell, W.A., Bruch, S., Bartlett, J.A., Waskin, H.A., Perfect, J.R., 1993. Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 37, 2449-2453.
4. Casadevall, A., Spitzer, E.D., Webb, D., Rinaldi, M.G., 1993. Susceptibilities of serial Cryptococcus neoformans isolates from patients with recurrent cryptococcal meningitis to amphotericin B and fluconazole. Antimicrob. Agents Chemother. 37, 1383-1386.
5. Denyer, S.P., Hugo, W.B., Harding, V.D., 1985. Synergy in preservative combinations. Int. J. Pharm. 25, 245-253.
6. Fromtling, R.A., Galgiani, J.N., Pfaller, M.A., Espinel-Ingroff, A., Bartizal, K.F., Bartlett, M.S., Body, B.A., Frey, C., Hall, G., Roberts, G.D., Nolle, F.B., Odds, F.C., Rinaldi, M.G., Sugar, A.M., Villareal, K., 1993. Multicentre evaluation of a broth macrodilution antifungal susceptibility test for yeasts. Antimicrob. Agents Chemother. 37, 39-45.
7. Galgiani, J.N., Reiser, J., Brass, C., Espinel-Ingroff, A., Gordon, M.A., Kerkering, T.M., 1987. Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods. Antimicrob. Agents Chemother. 31, 1343-1347.
8. Galgiani, J.N., Rinaldi, M.G., Polak, A.M., Pfaller, M.A., 1992. Standardization of antifungal susceptibility testing. J. Med. Vet. Mycol. 30 (Suppl. 1), 213-224.
9. Gallagher, P.J., 1994. Studies on the actions of antifungal drugs on oral isolates of Candida albicans. PhD thesis, University of Dublin, Trinity College, Ireland.
10. Gallagher, P.J., Bennett, D.E., Henman, M.C., Russell, R.J., Flint, S.R., Shanley, D.B., Coleman, D.C., 1992. Reduced azole susceptiblity of oral isolates of Candida albicans from HIV-positive patients and a derivative exhibiting colony morphology variation. J. Gen. Microbiol. 138, 1901-1911.
11. Greenwood, D., 1995. Antimicrobial Chemotherapy, 3rd edn. Oxford University Press, Oxford, pp. 119-127.
12. Hudson, L., Hay, F.C., 1989. Practical Immunology, 3rd ed. Blackwell, Oxford, pp. 94-95.
13. Hughes, C.E., Bennett, R.L., Tuna, I.C., Beggs, W.H., 1988. Activities of fluconazole (UK 49, 858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans. Antimicrob. Agents Chemother. 32, 209-212.
14. Johnson, E.M., Warnock, D.W., Luker, J., Porter, S.R., Scully, C., 1995. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidosis. J. Antimicrob. Chemother. 35, 103-114.
15. Mikami, Y., Takahashi, A., Yazawa, K., Terao, K., Ueno, Y., 1992. Synergistic interaction of miconazole and fluconazole at sub-MIC level on Candida albicans. Mycoses 35, 321-327.
16. Nair, M.K., Chien, Y.W., 1996. Development of anticandidal delivery systems. I. Anticandidal activities of antifungal agents and synergistic combination with other drugs. Drug. Dev. Ind. Pharm. 22, 237-242.
17. Odds, F.C., 1982. Interactions among amphotericin B, 5-fluorocytosine, ketoconazole and miconazole against pathogenic fungi in vitro. Antimicrob. Agents Chemother. 22, 763-770.
18. Odds, F.C. 1988. Candida and Candidosis: A Review and Bibliography, 2nd ed. Balliere Tindall, London.
19. Pedersen, M., Edelsten, M., Nielsen, V.F., Scarpellini, A., Skytte, S., Slot, C., 1993. Formation and antimycotic effect of cyclodextrin inclusion complexes of econazole and miconazole. Int. J. Pharm. 90, 247-254.
20. Pfaller, M.A., Rinaldi, M.G., Galgiani, J.N., Bartlett, M.S., Body, B.A., Espinel-Ingroff, A., Fromtling, R.A., Hall, G.S., Hughes, C.E., Odds, F.C., Sugar, A.M., 1990. Collaborative investigation of variables in susceptibility testing of yeasts. Antimicrob. Agents Chemother. 34, 1648-1654.
21. Scott, E.M., Tariq, V.N., McCrory, R.M., 1995. Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate or propylparaben against Candida albicans in vitro. Antimicrob. Agents Chemother. 39, 2610-2614.